Edition:
India

Trovagene Inc (TROV.OQ)

TROV.OQ on NASDAQ Stock Exchange Capital Market

0.74USD
2:29am IST
Change (% chg)

$-0.04 (-5.13%)
Prev Close
$0.78
Open
$0.75
Day's High
$0.78
Day's Low
$0.74
Volume
45,377
Avg. Vol
230,543
52-wk High
$7.66
52-wk Low
$0.65

Chart for

About

Trovagene, Inc. is a clinical-stage, precision medicine oncology therapeutics company. The Company’s lead drug candidate, PCM-075, is a Polo-like Kinase 1 (PLK1) selective adenosine triphosphate (ATP) competitive inhibitor. PCM-075 has shown preclinical antitumor activity as a single agent and in synergy combinations with more... (more)

Overall

Beta: 0.37
Market Cap(Mil.): $31.68
Shares Outstanding(Mil.): 37.27
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates